Safe Implementation of Treatments in Stroke’s Customers
See why customers chose Safe Implementation of Treatments in Stroke's products and services. Safe Implementation of Treatments in Stroke's customers include Parexel.
Parexel provides biopharmaceutical services that include a broad range of expertise-based contract research, consulting, medical communications, and t…
According to the World Health Organization, 15 million people suffer from stroke worldwide each year, and with the aging population, biopharmaceutical companies are turning to PAREXEL with respect to an increasing number of clinical programs focused on advancing new stroke treatments.
Compete with Safe Implementation of Treatments in Stroke?
Brief our analysts.
Get in front of tech buyers.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.